Sertraline Hydrochloride
- Product NDC
- 71610-435
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sertraline Hydrochloride
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- ANDA077206
- Marketing category
- ANDA
- Substance
- SERTRALINE HYDROCHLORIDE
- Current FDA listing
- Yes
Packages
| Package NDC | Description | Marketing start | Marketing end | Sample | Status |
|---|
| 71610-435-45 | 45 TABLET, FILM COATED in 1 BOTTLE (71610-435-45) | 2020-06-16 | | No | Historical |
| 71610-435-53 | 60 TABLET, FILM COATED in 1 BOTTLE (71610-435-53) | 2020-06-16 | | No | Historical |
| 71610-435-60 | 90 TABLET, FILM COATED in 1 BOTTLE (71610-435-60) | 2020-06-30 | | No | Historical |
| 71610-435-73 | 135 TABLET, FILM COATED in 1 BOTTLE (71610-435-73) | 2020-06-16 | | No | Historical |
| 71610-435-80 | 180 TABLET, FILM COATED in 1 BOTTLE (71610-435-80) | 2020-06-16 | | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Sertraline Hydrochloride | Aphena Pharma Solutions - Tennessee, LLC | 2020-06-23 | Human Prescription Drug Label | 2 |